bilaterals.org logo
bilaterals.org logo

intellectual property


TPP text shows some impacts from community campaigns, but still favours corporate rights over citizens and communities
Preliminary analysis of the thousands of pages of the main chapters of the TPP text show there are still devils in the detail on medicine monopolies, investor rights to sue governments and copyright monopolies.
Despite assurances to contrary, intellectual property covered asset for TPP ISDS mechanism
Despite assurances from the contrary by Australia and USTR, intellectual property is a covered asset subject to Investor State Dispute Settlement
Will the Trans Pacific Partnership have an impact on Indian pharma industry?
Implications of the TPP on the Indian pharma industry might not be entirely clear yet. But there is a need for India to engage in the debate of trade deals and public interest.
What the Internet needs vs. What the TPP demands
Who should make the policies that will determine the future of the Internet? A select list of corporate lobbyists and unelected government officials, meeting without public oversight or involvement?
Why Internet users should be very angry about the TPP
The TPP is about a lot more than dairy and cars – it’s also about our fundamental right to free expression.
India must resist US pressure on generic drugs, African leaders to tell Modi
So far, the NDA government has been a mute spectator to the US pharma strategy of forcing Indian generics manufacturers to produce only what is required for Indian consumers and abandon the export of cheap drugs to Africa
USITC Report on India (#2) now available
The United States International Trade Commission (USITC) has published a report on IPR policy transparency by India’s new government
Internet transformed under TPP, advocates tell Trudeau
Secret trade deal invites censorship? Leak suggests it, says digital rights group.
How trade agreements harm open access and open source
Open access isn’t explicitly covered in any of the secretive trade negotiations that are currently underway but that doesn’t mean that they won’t have a negative impact on those seeking to publish or use open access materials.
The problem with tying health care to trade
Writing pharmaceutical regulations into international trade deals can have costly consequences.
What the Trans-Pacific Partnership means for the cost of drugs
A quick analysis of the leaked text shows there are good reasons to be concerned that the TPP’s generous IP protections could still prove a minefield for efforts to control drug costs in Canada
FACIL contre le Partenariat transpacifique et la Loi antiterroriste de 2015
FACIL tient à affirmer publiquement son opposition au PTP. La version finale du chapitre sur la propriété intellectuelle confirme les craintes des principaux organismes qui défendent les droits et les libertés des humains dans la société numérique.
Drugs row threatens health sector budget
Ahead of a meeting between Indian Prime Minister Modi and German Chancellor Merkel this week, European manufacturers had already protested India’s patents policy, arguing that it doesn’t protect sensitive technology.
Preliminary comments on the completed Trans Pacific Partnership (TPP) intellectual property chapter
The TPP’s intellectual property chapter represents nothing less than a disaster for global health. Many harmful provisions still remain in the final chapter, bearing out the concerns of public health advocates.
The final leaked TPP text is all that we feared
The release of the current and essentially final version of the intellectual property (IP) chapter of the Trans-Pacific Partnership (TPP) confirms our worst fears about the agreement.
TPP - intellectual property chapter (October 2015)
As leaked by Wikileaks
India-EU FTA: time for a fundamental rethink?
India and EU would soon resume negotiations on the stalled India-EU free trade agreement.
Singapore concludes free trade negotiations with Turkey
Turkey and Singapore have concluded negotiations for the Turkey-Singapore Free Trade Agreement.
Some highlights of the new 12-country Trans-Pacific Partnership trade deal
Some highlights of the 12-country Trans-Pacific Partnership agreement as described by the Canadian government Monday as it shared details of a deal to create the largest-ever regional trading bloc.
Trans-Pacific Partnership: ’50/50’ chance of trade deal today as negotiators lock horns over medical patent protection
Australia — along with others such as New Zealand and Chile — has been unwilling to offer more than five years protection for the medicines, because longer terms would increase the cost of state-subsidised medical programs.